HomeTagsBiolinq

Biolinq

Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin

This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version